Expression of MT-III has been observed in different neurological diseases; however, the molecular mechanisms of MT-III downregulation in neurodegenerative disease are not yet known, and unfortunately there are several reports with conflicting results of MT-III function in AD. The gene discussed is MT3; the disease is nervous system disorder.